Ubs Group Ag Veru Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Veru Inc. stock. As of the latest transaction made, Ubs Group Ag holds 64,427 shares of VERU stock, worth $45,743. This represents 0.0% of its overall portfolio holdings.

Number of Shares

64,427

Previous 42,281 52.38%

Holding current value

$45,743

Previous $35,000 40.0%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.77 - $1.04 $17,052 - $23,031	22,146 Added 52.38%	64,427 $49,000
Q2 2024 Aug 13, 2024	BUY	$0.76 - $1.79 $30,033 - $70,737	39,518 Added 1430.26%	42,281 $35,000
Q1 2024 May 13, 2024	SELL	$0.37 - $0.72 $5,390 - $10,489	-14,569 Reduced 84.06%	2,763 $1,000
Q4 2023 Feb 09, 2024	BUY	$0.67 - $1.17 $9,401 - $16,417	14,032 Added 425.21%	17,332 $12,000
Q3 2023 Nov 09, 2023	SELL	$0.72 - $1.33 $16,863 - $31,151	-23,422 Reduced 87.65%	3,300 $2,000
Q2 2023 Aug 11, 2023	SELL	$0.98 - $1.49 $19 - $29	-20 Reduced 0.07%	26,722 $31,000
Q1 2023 May 12, 2023	SELL	$1.16 - $6.41 $27,406 - $151,442	-23,626 Reduced 46.91%	26,742 $31,000
Q4 2022 Feb 08, 2023	BUY	$4.78 - $15.01 $80,217 - $251,897	16,782 Added 49.97%	50,368 $265,000
Q3 2022 Nov 10, 2022	SELL	$10.22 - $23.7 $57,538 - $133,431	-5,630 Reduced 14.36%	33,586 $387,000
Q2 2022 Aug 10, 2022	BUY	$4.35 - $15.85 $3,871 - $14,106	890 Added 2.32%	39,216 $443,000
Q1 2022 May 16, 2022	SELL	$4.55 - $6.41 $118,937 - $167,557	-26,140 Reduced 40.55%	38,326 $185,000
Q4 2021 Feb 14, 2022	BUY	$5.89 - $9.73 $71,905 - $118,783	12,208 Added 23.36%	64,466 $380,000
Q3 2021 Nov 15, 2021	SELL	$6.78 - $9.89 $262,202 - $382,475	-38,673 Reduced 42.53%	52,258 $446,000
Q2 2021 Aug 13, 2021	BUY	$7.24 - $11.2 $194,929 - $301,548	26,924 Added 42.06%	90,931 $734,000
Q1 2021 May 12, 2021	SELL	$8.05 - $20.78 $18,845 - $48,645	-2,341 Reduced 3.53%	64,007 $689,000
Q4 2020 Feb 11, 2021	BUY	$2.36 - $9.99 $7,606 - $32,197	3,223 Added 5.11%	66,348 $574,000
Q3 2020 Nov 12, 2020	SELL	$2.58 - $3.36 $37,649 - $49,032	-14,593 Reduced 18.78%	63,125 $165,000
Q2 2020 Jul 31, 2020	BUY	$3.01 - $4.02 $43,118 - $57,586	14,325 Added 22.6%	77,718 $260,000
Q1 2020 May 01, 2020	BUY	$2.58 - $4.58 $127,898 - $227,044	49,573 Added 358.7%	63,393 $207,000
Q4 2019 Feb 14, 2020	SELL	$1.86 - $3.35 $9,022 - $16,250	-4,851 Reduced 25.98%	13,820 $46,000
Q3 2019 Nov 14, 2019	SELL	$1.81 - $2.36 $2,018 - $2,631	-1,115 Reduced 5.64%	18,671 $41,000
Q2 2019 Aug 14, 2019	BUY	$1.26 - $2.14 $7,617 - $12,938	6,046 Added 44.0%	19,786 $42,000
Q1 2019 May 14, 2019	SELL	$1.2 - $1.59 $6,562 - $8,695	-5,469 Reduced 28.47%	13,740 $20,000
Q4 2018 Feb 14, 2019	BUY	$1.21 - $1.54 $3,075 - $3,914	2,542 Added 15.25%	19,209 $27,000
Q3 2018 Nov 14, 2018	BUY	$1.38 - $2.27 $4,039 - $6,644	2,927 Added 21.3%	16,667 $24,000
Q2 2018 Aug 14, 2018	SELL	$1.64 - $2.29 $10,728 - $14,981	-6,542 Reduced 32.26%	13,740 $28,000
Q1 2018 May 15, 2018	SELL	$1.19 - $2.17 $264 - $481	-222 Reduced 1.08%	20,282 $36,000
Q4 2017 Feb 14, 2018	SELL	$0.98 - $2.27 $757 - $1,754	-773 Reduced 3.63%	20,504 $23,000
Q3 2017 Nov 14, 2017	BUY	$1.2 - $2.84 $25,532 - $60,426	21,277	21,277 $56,000

Others Institutions Holding VERU

# of Institutions

123

Shares Held

56.9M

Call Options Held

668K

Put Options Held

531K

View Full List

About VERU INC.

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $56.9M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

More about VERU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account